Peer-Reviewed Journal Details
Mandatory Fields
Hayes, M,Stanton, C,Slattery, H,O'Sullivan, O,Hill, C,Fitzgerald, GF,Ross, RP
2007
July
Applied and Environmental Microbiology
Casein fermentate of Lactobacillus animalis DPC6134 contains a range of novel propeptide angiotensin-converting enzyme inhibitors
Validated
WOS: 92 ()
Optional Fields
LACTIC-ACID BACTERIA BIOACTIVE PEPTIDES BETA-CASEIN LACTOCOCCUS-LACTIS BOUND PROTEINASE MILK-PROTEINS HYDROLYSATE BINDING RECONSTRUCTION IDENTIFICATION
73
4658
4667
This work evaluated the angiotensin-converting-enzyme (ACE) -inhibitory activities of a bovine sodium caseinate fermentate generated using the proteolytic capabilities of the porcine small intestinal isolate Lactobacillus animalis DPC6134 (NCIMB deposit 41355). The crude 10-kDa L. animalis DPC6134 fermentate exhibited ACE-inhibitory activity of 85.51% (+/- 15%) and had a 50% inhibitory concentration (IC50) of 0-8 mg protein/ml compared to captopril, which had an IC50 value of 0.005 mg/ml. Fractionation of the crude L. animalis DPC6134 fermentate by membrane filtration and reversed-phase high-performance liquid chromatography (HPLC) generated three bioactive fractions from a total of 72 fractions. Fractions 10, 19, and 43 displayed ACE-inhibitory activity percentages of 67.53 (+/- 15), 83.71 (+/- 19), and 42.36 (+/- 11), respectively, where ACE inhibition was determined with 80 mu l of the fractions with protein concentrations of 0.5 mg/ml. HPLC and mass spectrometry analysis identified 25 distinct peptide sequences derived from alpha-, beta-, and kappa-caseins. In silico predictions, based on the C-terminal tetrapeptide sequences, suggested that peptide NIPPLTQTPWVPPFIQ, corresponding to beta-casein f(73-89); peptide IGSENSEKTTMP, corresponding to alpha(s1)-casein f(201212); peptide SQSKVLPVPQ, corresponding to beta-casein f(166-175); peptide MPFPKYPVEP, corresponding to beta-casein f(124133); and peptide EPVLGPVRGPFP, corresponding to R-casein f(210-221), contained ACE-inhibitory activities. These peptides were chosen for chemical synthesis to confirm the ACE-inhibitory activity of the fractions. Chemically synthesized peptides displayed IC50 values in the range of 92 mu M to 790 mu M. Additionally, a simulated gastrointestinal digestion confirmed that the ACE-inhibitory 10-kDa L. animalis DPC6134 fermentation was resistant to a cocktail of digestive enzymes found in the gastrointestinal tract.
10.1128/AEM.00096-07
Grant Details